Serum autoantibodies against the extracellular region of α6β4 integrin in a patient with dipeptidyl peptidase-4 inhibitor-induced bullous pemphigoid
Saved in:
Main Authors: | Chigusa Yamashita, MD (Author), Noriko Arase, MD, PhD (Author), Shuhei Higuchi, MS (Author), Hisashi Arase, MD, PhD (Author), Junichi Takagi, PhD (Author), Satoshi Nojima, MD, PhD (Author), Atsushi Tanemura, MD, PhD (Author), Manabu Fujimoto, MD, PhD (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2022-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efficacy and Safety of the Dipeptidyl Peptidase-4 Inhibitor Sitagliptin on Atherosclerosis, β-Cell Function, and Glycemic Control in Japanese Patients with Type 2 Diabetes Mellitus Who are Treatment Naïve or Poorly Responsive to Antidiabetes Agents: A Multicenter, Prospective Observational, Uncontrolled Study
by: Yuya Tsurutani, MD, PhD, et al.
Published: (2017) -
An Acceptance and Commitment Therapy Smartphone Application for Erectile Dysfunction: A Feasibility Study
by: Junichi Saito, PhD, et al.
Published: (2023) -
Lethal Carmi syndrome (junctional epidermolysis bullosa-pyloric atresia) with a novel and recurrent compound integrin beta 4 heterozygous mutation: A case report
by: Suci Widhiati, MD, PhD, et al.
Published: (2024) -
Diffuse Large B-Cell Lymphoma 18 Years After Bilateral Lacrimal Gland IgG4-Related Disease: Case Report and Literature Review
by: Toshihiko Matsuo MD, PhD, et al.
Published: (2022) -
Clinical-histopathological features and cancer gene analysis of cutaneous epithelioid angiosarcoma: A report of 4 cases
by: Keiko Tokuchi, MD, PhD, et al.
Published: (2024)